AbbVie Baxter Golden Cross: One Signal Proves Real
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Methods for cost control focus on rigorous allocation and review cycles, enabling proactive adjustments to keep spending in check.
22,894 articlesTwo pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Strategy's Phong Le anchors the firm's crypto stance to a debt-risk threshold at $8K–$10K, underscoring balance-sheet...
Oklo has shed 28% over the past month as investors rotate away from pre-revenue nuclear developers. Utilities remain ...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
IBM’s market collapse is forcing a reckoning on its future strategy as Microsoft and Apple deepen AI and cloud leader...
A mid-cap tech stock has quietly outperformed NVIDIA on a three-year price-return basis, triggering renewed interest ...
Booking Holdings trades at elevated levels, reigniting debate over whether a stock split could broaden retail ownersh...
Stocks wiggle as CoreWeave drops on news of Blue Owl’s failed $4B debt placement. Experts say the financing hiccup co...
US search interest in Bitcoin has surged to a five-year high even as prices remain in a bear market. Traders watch wh...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
As memory prices surge in 2026, Corsair Gaming emerges as the leading beneficiary with improved margins, a new buybac...